{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:07:51Z","timestamp":1790788071599,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T00:00:00Z","timestamp":1673654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T00:00:00Z","timestamp":1673654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"crossref","award":["312041"],"award-info":[{"award-number":["312041"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"crossref","award":["335823"],"award-info":[{"award-number":["335823"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007797","name":"University of Helsinki","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007797","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004756","name":"The Emil Aaltonen foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004756","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003756","name":"Biomedicum Helsinki-s\u00e4\u00e4ti\u00f6","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003756","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007083","name":"Orionin Tutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007083","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ida Montinin S\u00e4\u00e4ti\u00f6"},{"name":"iCAN Digital Precision Cancer Medicine Flagship","award":["320185"],"award-info":[{"award-number":["320185"]}]},{"name":"Academy Professorship","award":["319083"],"award-info":[{"award-number":["319083"]}]},{"name":"Academy Professorship","award":["320149"],"award-info":[{"award-number":["320149"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Accurate regulation of DNA methylation is necessary for normal cells to differentiate, develop and function. TET2 catalyzes stepwise DNA demethylation in hematopoietic cells. Mutations in the <jats:italic>TET2<\/jats:italic> gene predispose to hematological malignancies by causing DNA methylation overload and aberrant epigenomic landscape. Studies on mice and cell lines show that the function of TET2 is boosted by vitamin C. Thus, by strengthening the demethylation activity of TET2, vitamin C could play a role in the prevention of hematological malignancies in individuals with TET2 dysfunction. We recently identified a family with lymphoma predisposition where a heterozygous truncating germline mutation in <jats:italic>TET2<\/jats:italic> segregated with nodular lymphocyte-predominant Hodgkin lymphoma. The mutation carriers displayed a hypermethylation pattern that was absent in the family members without the mutation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In a clinical trial of 1 year, we investigated the effects of oral 1\u00a0g\/day vitamin C supplementation on DNA methylation by analyzing genome-wide DNA methylation and gene expression patterns from the family members.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We show that vitamin C reinforces the DNA demethylation cascade, reduces the proportion of hypermethylated loci and diminishes gene expression differences between <jats:italic>TET2<\/jats:italic> mutation carriers and control individuals.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These results suggest that vitamin C supplementation increases DNA methylation turnover and provide a basis for further work to examine the potential benefits of vitamin C supplementation in individuals with germline and somatic <jats:italic>TET2<\/jats:italic> mutations.<\/jats:p>\n                <jats:p><jats:italic>Trial registration<\/jats:italic>: This trial was registered at EudraCT with reference number of 2018-000155-41 (01.04.2019).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s13148-022-01404-6","type":"journal-article","created":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T04:29:02Z","timestamp":1673670542000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Vitamin C boosts DNA demethylation in TET2 germline mutation carriers"],"prefix":"10.1186","volume":"15","author":[{"given":"Aurora","family":"Taira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimmo","family":"Palin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kuosmanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niko","family":"V\u00e4lim\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Outi","family":"Kuittinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Outi","family":"Kuismin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eevi","family":"Kaasinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristiina","family":"Rajam\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauri A.","family":"Aaltonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,14]]},"reference":[{"key":"1404_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/B978-0-12-380866-0.60002-2","volume":"70","author":"M Kulis","year":"2010","unstructured":"Kulis M, Esteller M. DNA methylation and cancer. Adv Genet. 2010;70:27\u201356.","journal-title":"Adv Genet"},{"key":"1404_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13073-015-0134-6","volume":"7","author":"L Scourzic","year":"2015","unstructured":"Scourzic L, Mouly E, Bernard OA. TET proteins and the control of cytosine demethylation in cancer. Genome Med. 2015;7:9.","journal-title":"Genome Med"},{"key":"1404_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12185-016-2122-z","volume":"105","author":"S Chiba","year":"2017","unstructured":"Chiba S. Dysregulation of TET2 in hematologic malignancies. Int J Hematol. 2017;105:17\u201322.","journal-title":"Int J Hematol"},{"key":"1404_CR4","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/leu.2013.337","volume":"28","author":"E Solary","year":"2014","unstructured":"Solary E, Bernard OA, Tefferi A, Fuks F, Vainchenker W. The ten-eleven translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases. Leukemia. 2014;28:485\u201396.","journal-title":"Leukemia"},{"key":"1404_CR5","doi-asserted-by":"publisher","first-page":"10396","DOI":"10.1021\/ja4028346","volume":"135","author":"R Yin","year":"2013","unstructured":"Yin R, Mao S-Q, Zhao B, Chong Z, Yang Y, Zhao C, et al. Ascorbic acid enhances Tet-mediated 5-methylcytosine oxidation and promotes DNA demethylation in mammals. J Am Chem Soc. 2013;135:10396\u2013403.","journal-title":"J Am Chem Soc"},{"key":"1404_CR6","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/nbt.3073","volume":"32","author":"H Wu","year":"2014","unstructured":"Wu H, Wu X, Shen L, Zhang Y. Single-base resolution analysis of active DNA demethylation using methylase-assisted bisulfite sequencing. Nat Biotechnol. 2014;32:1231\u201340.","journal-title":"Nat Biotechnol"},{"key":"1404_CR7","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s42003-020-01220-9","volume":"3","author":"Y Guan","year":"2020","unstructured":"Guan Y, Greenberg EF, Hasipek M, Chen S, Liu X, Kerr CM, et al. Context dependent effects of ascorbic acid treatment in TET2 mutant myeloid neoplasia. Commun Biol. 2020;3:493.","journal-title":"Commun Biol"},{"key":"1404_CR8","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/nature23876","volume":"549","author":"M Agathocleous","year":"2017","unstructured":"Agathocleous M, Meacham CE, Burgess RJ, Piskounova E, Zhao Z, Crane GM, et al. Ascorbate regulates haematopoietic stem cell function and leukaemogenesis. Nature. 2017;549:476\u201381.","journal-title":"Nature"},{"key":"1404_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1497.2006.00483.x","author":"ID Coulter","year":"2006","unstructured":"Coulter ID, Hardy ML, Morton SC, Hilton LG, Tu W, Valentine, et al. Antioxidants vitamin C and vitamin E for the prevention and treatment of cancer [Internet]. J Gen Internal Med. 2006. https:\/\/doi.org\/10.1111\/j.1525-1497.2006.00483.x.","journal-title":"J Gen Internal Med"},{"key":"1404_CR10","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature12362","volume":"500","author":"K Blaschke","year":"2013","unstructured":"Blaschke K, Ebata KT, Karimi MM, Zepeda-Mart\u00ednez JA, Goyal P, Mahapatra S, et al. Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells. Nature. 2013;500:222\u20136.","journal-title":"Nature"},{"key":"1404_CR11","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.cell.2017.07.032","volume":"170","author":"L Cimmino","year":"2017","unstructured":"Cimmino L, Dolgalev I, Wang Y, Yoshimi A, Martin GH, Wang J, et al. Restoration of TET2 function blocks aberrant self-renewal and leukemia progression. Cell. 2017;170:1079-95.e20.","journal-title":"Cell"},{"key":"1404_CR12","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1038\/s41467-019-09198-7","volume":"10","author":"E Kaasinen","year":"2019","unstructured":"Kaasinen E, Kuismin O, Rajam\u00e4ki K, Ristolainen H, Aavikko M, Kondelin J, et al. Impact of constitutional TET2 haploinsufficiency on molecular and clinical phenotype in humans. Nat Commun. 2019;10:1252.","journal-title":"Nat Commun"},{"key":"1404_CR13","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1073\/pnas.93.8.3704","volume":"93","author":"M Levine","year":"1996","unstructured":"Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR, et al. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci U S A. 1996;93:3704\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1404_CR14","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1093\/bioinformatics\/bty191","volume":"34","author":"H Li","year":"2018","unstructured":"Li H. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics. 2018;34:3094\u2013100.","journal-title":"Bioinformatics"},{"key":"1404_CR15","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1093\/bioinformatics\/bty149","volume":"34","author":"W De Coster","year":"2018","unstructured":"De Coster W, D\u2019Hert S, Schultz DT, Cruts M, Van Broeckhoven C. NanoPack: visualizing and processing long-read sequencing data. Bioinformatics. 2018;34:2666\u20139.","journal-title":"Bioinformatics"},{"key":"1404_CR16","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nmeth.4184","volume":"14","author":"JT Simpson","year":"2017","unstructured":"Simpson JT, Workman RE, Zuzarte PC, David M, Dursi LJ, Timp W. Detecting DNA cytosine methylation using nanopore sequencing. Nat Methods. 2017;14:407\u201310.","journal-title":"Nat Methods"},{"key":"1404_CR17","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature14248","volume":"518","author":"A Kundaje","year":"2015","unstructured":"Roadmap Epigenomics Consortium, Kundaje A, Meuleman W, Ernst J, Bilenky M, Yen A, et al. Integrative analysis of 111 reference human epigenomes. Nature. 2015;518:317\u201330.","journal-title":"Nature"},{"key":"1404_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature11247","volume":"489","author":"ENCODE Project Consortium","year":"2012","unstructured":"ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489:57\u201374.","journal-title":"Nature"},{"key":"1404_CR19","doi-asserted-by":"publisher","first-page":"D794","DOI":"10.1093\/nar\/gkx1081","volume":"46","author":"CA Davis","year":"2018","unstructured":"Davis CA, Hitz BC, Sloan CA, Chan ET, Davidson JM, Gabdank I, et al. The encyclopedia of DNA elements (ENCODE): data portal update. Nucl Acids Res. 2018;46:D794-801.","journal-title":"Nucl Acids Res"},{"key":"1404_CR20","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37:773\u201382.","journal-title":"Nat Biotechnol"},{"key":"1404_CR21","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.molcel.2014.08.026","volume":"56","author":"GC Hon","year":"2014","unstructured":"Hon GC, Song C-X, Du T, Jin F, Selvaraj S, Lee AY, et al. 5mC oxidation by Tet2 modulates enhancer activity and timing of transcriptome reprogramming during differentiation. Mol Cell. 2014;56:286\u201397.","journal-title":"Mol Cell"},{"key":"1404_CR22","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1101\/gad.260174.115","volume":"29","author":"KD Rasmussen","year":"2015","unstructured":"Rasmussen KD, Jia G, Johansen JV, Pedersen MT, Rapin N, Bagger FO, et al. Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis. Genes Dev. 2015;29:910\u201322.","journal-title":"Genes Dev"},{"key":"1404_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.stem.2008.11.011","volume":"4","author":"K Cui","year":"2009","unstructured":"Cui K, Zang C, Roh T-Y, Schones DE, Childs RW, Peng W, et al. Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell Stem Cell. 2009;4:80\u201393.","journal-title":"Cell Stem Cell"},{"key":"1404_CR24","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1111\/j.1476-5381.2011.01350.x","volume":"164","author":"JM May","year":"2011","unstructured":"May JM. The SLC23 family of ascorbate transporters: ensuring that you get and keep your daily dose of vitamin C. Br J Pharmacol. 2011;164:1793\u2013801.","journal-title":"Br J Pharmacol"},{"key":"1404_CR25","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.5b10554","author":"DJ Crawford","year":"2016","unstructured":"Crawford DJ, Liu MY, Nabel CS, Cao X-J, Garcia BA, Kohli RM. Tet2 catalyzes stepwise 5-methylcytosine oxidation by an iterative and de novo mechanism [Internet]. J Am Chem Soc. 2016. https:\/\/doi.org\/10.1021\/jacs.5b10554.","journal-title":"J Am Chem Soc"},{"key":"1404_CR26","doi-asserted-by":"publisher","first-page":"6061","DOI":"10.1038\/s41467-021-26093-2","volume":"12","author":"M Tulstrup","year":"2021","unstructured":"Tulstrup M, Soerensen M, Hansen JW, Gillberg L, Needhamsen M, Kaastrup K, et al. TET2 mutations are associated with hypermethylation at key regulatory enhancers in normal and malignant hematopoiesis. Nat Commun. 2021;12:6061.","journal-title":"Nat Commun"},{"key":"1404_CR27","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-14-0739","author":"J Yamazaki","year":"2015","unstructured":"Yamazaki J, Jelinek J, Lu Y, Cesaroni M, Madzo J, Neumann F, et al. TET2 mutations affect non-CpG Island DNA methylation at enhancers and transcription factor-binding sites in chronic myelomonocytic leukemia [Internet]. Cancer Res. 2015. https:\/\/doi.org\/10.1158\/0008-5472.can-14-0739.","journal-title":"Cancer Res"},{"key":"1404_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3522","author":"O Bogdanovi\u0107","year":"2016","unstructured":"Bogdanovi\u0107 O, Smits AH, de la Calle ME, Tena JJ, Ford E, Williams R, et al. Active DNA demethylation at enhancers during the vertebrate phylotypic period [Internet]. Nat Genet. 2016. https:\/\/doi.org\/10.1038\/ng.3522.","journal-title":"Nat Genet"},{"key":"1404_CR29","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.stem.2018.11.001","volume":"23","author":"JL Sardina","year":"2018","unstructured":"Sardina JL, Collombet S, Tian TV, G\u00f3mez A, Di Stefano B, Berenguer C, et al. Transcription factors drive Tet2-mediated enhancer demethylation to reprogram cell fate. Cell Stem Cell. 2018;23:905\u20136.","journal-title":"Cell Stem Cell"},{"key":"1404_CR30","doi-asserted-by":"publisher","first-page":"13669","DOI":"10.1074\/jbc.C113.464800","volume":"288","author":"EA Minor","year":"2013","unstructured":"Minor EA, Court BL, Young JI, Wang G. Ascorbate induces ten-eleven translocation (Tet) methylcytosine dioxygenase-mediated generation of 5-hydroxymethylcytosine. J Biol Chem. 2013;288:13669\u201374.","journal-title":"J Biol Chem"},{"key":"1404_CR31","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1126\/science.1212483","volume":"334","author":"A Inoue","year":"2011","unstructured":"Inoue A, Zhang Y. Replication-dependent loss of 5-hydroxymethylcytosine in mouse preimplantation embryos. Science. 2011;334:194.","journal-title":"Science"},{"key":"1404_CR32","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s13059-021-02510-z","volume":"22","author":"Y Liu","year":"2021","unstructured":"Liu Y, Rosikiewicz W, Pan Z, Jillette N, Wang P, Taghbalout A, et al. DNA methylation-calling tools for Oxford nanopore sequencing: a survey and human epigenome-wide evaluation. Genome Biol. 2021;22:295.","journal-title":"Genome Biol"},{"key":"1404_CR33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nchembio.2250","volume":"13","author":"MY Liu","year":"2017","unstructured":"Liu MY, Torabifard H, Crawford DJ, DeNizio JE, Cao X-J, Garcia BA, et al. Mutations along a TET2 active site scaffold stall oxidation at 5-hydroxymethylcytosine. Nat Chem Biol. 2017;13:181\u20137.","journal-title":"Nat Chem Biol"},{"key":"1404_CR34","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.molcel.2020.11.045","volume":"81","author":"BA Caldwell","year":"2021","unstructured":"Caldwell BA, Liu MY, Prasasya RD, Wang T, DeNizio JE, Leu NA, et al. Functionally distinct roles for TET-oxidized 5-methylcytosine bases in somatic reprogramming to pluripotency. Mol Cell. 2021;81:859-69.e8.","journal-title":"Mol Cell"},{"key":"1404_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-019-0242-4","author":"AB Das","year":"2019","unstructured":"Das AB, Kakadia PM, Wojcik D, Pemberton L, Browett PJ, Bohlander SK, et al. Clinical remission following ascorbate treatment in a case of acute myeloid leukemia with mutations in TET2 and WT1 [Internet]. Blood Cancer J. 2019. https:\/\/doi.org\/10.1038\/s41408-019-0242-4.","journal-title":"Blood Cancer J"},{"key":"1404_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13148-019-0739-5","volume":"11","author":"L Gillberg","year":"2019","unstructured":"Gillberg L, \u00d8rskov AD, Nasif A, Ohtani H, Madaj Z, Hansen JW, et al. Oral vitamin C supplementation to patients with myeloid cancer on azacitidine treatment: normalization of plasma vitamin C induces epigenetic changes. Clin Epigenet. 2019;11:143.","journal-title":"Clin Epigenet"},{"key":"1404_CR37","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1182\/blood-2009-09-245381","volume":"115","author":"FX Schaub","year":"2010","unstructured":"Schaub FX, Looser R, Li S, Hao-Shen H, Lehmann T, Tichelli A, et al. Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms. Blood. 2010;115:2003\u20137.","journal-title":"Blood"},{"key":"1404_CR38","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1038\/s41375-019-0675-6","volume":"34","author":"N Duployez","year":"2020","unstructured":"Duployez N, Goursaud L, Fenwarth L, Bories C, Marceau-Renaut A, Boyer T, et al. Familial myeloid malignancies with germline TET2 mutation. Leukemia. 2020;34:1450\u20133.","journal-title":"Leukemia"},{"key":"1404_CR39","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1182\/blood.2020005844","volume":"136","author":"J Stremenova Spegarova","year":"2020","unstructured":"Stremenova Spegarova J, Lawless D, Mohamad SMB, Engelhardt KR, Doody G, Shrimpton J, et al. Germline TET2 loss of function causes childhood immunodeficiency and lymphoma. Blood. 2020;136:1055\u201366.","journal-title":"Blood"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-022-01404-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-022-01404-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-022-01404-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T04:29:28Z","timestamp":1673670568000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-022-01404-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,14]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1404"],"URL":"https:\/\/doi.org\/10.1186\/s13148-022-01404-6","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,14]]},"assertion":[{"value":"7 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been registered with the EudraCT reference number 2018-000155-41. The samples and patient information were obtained with approval from the ethics committee of the Hospital District of Helsinki and Uusimaa, the Northern Ostrobothnia Hospital District as well as National Supervisory Authority for Welfare and Health. Signed informed consent was obtained from all study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Signed informed consent for data publication was obtained from all study participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}